These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18724378)

  • 1. RPN2 gene confers docetaxel resistance in breast cancer.
    Honma K; Iwao-Koizumi K; Takeshita F; Yamamoto Y; Yoshida T; Nishio K; Nagahara S; Kato K; Ochiya T
    Nat Med; 2008 Sep; 14(9):939-48. PubMed ID: 18724378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer.
    Fujita Y; Yagishita S; Takeshita F; Yamamoto Y; Kuwano K; Ochiya T
    Oncotarget; 2015 Feb; 6(5):3335-45. PubMed ID: 25595901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers.
    Ooe A; Kato K; Noguchi S
    Breast Cancer Res Treat; 2007 Mar; 101(3):305-15. PubMed ID: 16821082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel.
    Losert D; Pratscher B; Soutschek J; Geick A; Vornlocher HP; Müller M; Wacheck V
    Anticancer Drugs; 2007 Aug; 18(7):755-61. PubMed ID: 17581297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis.
    Hernández-Vargas H; Palacios J; Moreno-Bueno G
    Oncogene; 2007 May; 26(20):2902-13. PubMed ID: 17099726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression.
    Yao YS; Qiu WS; Yao RY; Zhang Q; Zhuang LK; Zhou F; Sun LB; Yue L
    Oncol Rep; 2015 May; 33(5):2504-12. PubMed ID: 25813250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
    Feng B; Wang R; Chen LB
    Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity.
    Gordian E; Ramachandran K; Singal R
    Anticancer Res; 2009 Aug; 29(8):3207-10. PubMed ID: 19661336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation.
    De Iuliis F; Salerno G; Giuffrida A; Milana B; Taglieri L; Rubinacci G; Giantulli S; Terella F; Silvestri I; Scarpa S
    Tumour Biol; 2016 Feb; 37(2):2603-11. PubMed ID: 26392111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
    Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
    Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistant breast cancer cells overexpress ETS1 gene.
    Kars MD; Işeri OD; Gündüz U
    Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
    Dönmez Y; Gündüz U
    Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 4 ligation confers chemoresistance to docetaxel on PC-3 human prostate cancer cells.
    Zhang Y; Wang Y; Yuan J; Qin W; Liu F; Wang F; Zhang G; Yang X
    Cell Biol Toxicol; 2012 Aug; 28(4):269-77. PubMed ID: 22648782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The depletion of interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells.
    Shao N; Chen LH; Ye RY; Lin Y; Wang SM
    Biochem Biophys Res Commun; 2013 Feb; 431(3):535-41. PubMed ID: 23321310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting beta1 integrin restores sensitivity to docetaxel of esophageal squamous cell carcinoma.
    Mori R; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Tomoda K; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2008 Dec; 20(6):1345-51. PubMed ID: 19020712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of RNA interference for Lon gene silencing on growth and apoptosis of human breast cancer MCF7 cells].
    Xue X; Zhu YF; Mao JP
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):870-4. PubMed ID: 17584658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.